跳至主要内容
临床试验/KCT0009637
KCT0009637尚未招募Unknown

Single center, randomized, double blind, parallel design, prospective clinical trial to compare the safety and efficacy of remimazolam and dexmedetomidine used in sedation for extraction of third molars

Seoul National University Dental Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18(Year) 至 40(Year)(—)
性别
All

入选标准

  • 1. Patients who are aged between 18 and 40 years old
  • 2. Patients who are American Society of Anesthesiologists physical status I or II
  • 3. Patients who are scheduled to have extraction of all 4 third molars under sedation
  • 4. Patients with a body mass index (BMI) of 18.5 to 30 kg/m2

排除标准

  • 1. Patients with hypersensitivity or allergy to sedatives or local anesthetics
  • 2. Patients taking medications that may affect clinical trial results, such as pain relievers, sedatives, and psychiatric medications
  • 3. Patients with Mallampati Class III or IV
  • 4. Patients who are pregnant or breastfeeding
  • 5. Patients with liver, kidney or brain dysfunction
  • 6. Patients with sleep apnea
  • 7. Patients with myasthenia gravis
  • 8. Patient unable to read or understand consent form
  • 9. Other patients determined by the investigator to be excluded

研究者

相似试验